Semarion

United Kingdom
Cambridge, England, United Kingdom, CB3 0HE

Company profile

Semarion company profile

Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. Semarion combines microchip industry materials and techniques engineering and cell biology to tackle unmet drug screening needs.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
CB3 0HE
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$3.2M
Last funding
Seed / $2.9M / 2022-02-22
Last equity funding
Seed / $2.9M
Investors
4
Lead investors
2
Articles
19

Founders and investors

Lead investors

Parkwalk AdvisorsStart Codon

Investors

Martlet CapitalParkwalk AdvisorsStart CodonUniversity of Cambridge Enterprise